← Leaderboards
Elizabeth S Raveche
Univ Of Med/Dent Of Nj-Nj Medical School
$1,135,543
Attributed
$1,135,543
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $314K · FY2010–12$500K$375K$250K$125K$0
'10
'11
'12
Funding mix
By agency
NIH$1,135,543 · 2
By mechanism
R01$1,135,543 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Apoptosis”
- David Heimbrook · Leidos Biomedical Research, Inc.$49,205,802
- Jay A Nelson · Oregon Health & Science University$45,942,124
- John C Reed · University Of Texas Md Anderson Can Ctr$34,437,189
- John A Tainer · Scripps Research Institute$30,637,655
- Henry Shelton Earp · Univ Of North Carolina Chapel Hill$28,872,594
- John D Minna · University Of Texas Sw Med Ctr/Dallas$27,317,167
Research focus
ApoptosisDisease ResistanceApoptoticDefectDisease CharacteristicCancer Cell3&AposAffectAutoantibodiesAnti-Igm13q14AdjuvantDifferentiation And GrowthCell CycleCell Cycle RegulationCell LineCellsChemotherapyChromosomes, Human, Pair 14Chronic Lymphocytic LeukemiaCyclin D1CyclinsB-LymphocytesEmbryonic Stem Cell
Grant awards (4)
Studies of the role of microRNA miR-16-1 in the NZB mouse model of CLL$313,989
R01 · FY2012 · CA · contact PI
Studies of the role of microRNA miR-16-1 in the NZB mouse model of CLL$313,989
R01 · FY2011 · CA · contact PI
Studies of the role of microRNA miR-16-1 in the NZB mouse model of CLL$309,756
R01 · FY2010 · CA · contact PI
IMMUNOREGULATION BY UNIQUE AUTOIMMUNE LY1+ B CELLS$197,809
R01 · FY2000 · CA